Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007221 |
---|---|
Receipt number | R000008503 |
Scientific Title | Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib Therapy |
Date of disclosure of the study information | 2012/02/03 |
Last modified on | 2020/12/02 14:59:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/03 15:17:13 | ||
2 | Update | 2013/03/04 11:33:39 | Recruitment status |
|
3 | Update | 2020/08/12 15:51:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
4 | Update | 2020/12/02 14:59:14 | Recruitment status Date of IRB Last follow-up date Date analysis concluded |